Pictet Asset Management (Switzerland)’s Moderna MRNA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$166M	Buy	1,370,128 +56,453	+4%	+$7.53M	0.2%	137
2023 Q1	$202M	Buy	1,313,675 +52,414	+4%	+$8.65M	0.25%	119
2022 Q4	$227M	Buy	1,261,261 +901,274	+250%	+$147M	0.33%	84
2022 Q3	$42.6M	Buy	359,987 +44,165	+14%	+$6.7M	0.06%	293
2022 Q2	$45.1M	Buy	315,822 +72,730	+30%	+$10.4M	0.06%	299
2022 Q1	$41.9M	Sell	243,092 -10,675	-4%	-$1.8M	0.05%	348
2021 Q4	$64.5M	Sell	253,767 -3,851	-1%	-$1.13M	0.06%	302
2021 Q3	$99.1M	Buy	+257,618	New	+$95M	0.11%	226

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s MRNA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Moderna (MRNA) stake by 4.3% in Q2 2023, buying an estimated $7.53M and bringing the position to 1,370,128 shares worth $166M. The position accounts for 0.2% of the portfolio, ranked #137.

Pictet Asset Management (Switzerland) first reported a position in MRNA in Q3 2021 and has held it in 8 quarters since. The position peaked at $227M in Q4 2022. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,370,128 shares of Moderna worth $166M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 56,453 Moderna shares in Q2 2023, an estimated $7.53M.
Moderna made up 0.2% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #137 holding.
Pictet Asset Management (Switzerland) first reported a position in Moderna in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Moderna position peaked at $227M in Q4 2022.
966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.